Glucagonlike peptide1 receptor internalisation controls spatiotemporal signalling mediated by biased agonists
Hidradenitis suppurativa often clusters with obesity, diabetes and metabolic syndrome, and this review highlights growing evidence that glucagonlike peptide1 receptor agonists (GLP1RAs) could address both skin disease and its comorbidities
"Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data." International Journal of Molecular Sciences , 2018
BMC Gastroenterology , 17(1), 96
November 22, 2024: Researchers Say More Studies Should Examine GLP-1 Drugs, Like Mounjaro, And Cancer Risks A recent French study published in Endocrine Connections looked into data from patients who used GLP-1 drugs, like Mounjaro, for 1 to 3 years